Detalles de la búsqueda
1.
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
N Engl J Med
; 376(5): 417-428, 2017 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28146658
2.
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
Lancet Oncol
; 19(11): 1504-1515, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30316827
3.
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.
Eur Urol
; 85(4): 373-381, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36710205
4.
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202.
Eur Urol Focus
; 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38307806
5.
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial.
Eur Urol Oncol
; 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38302323
6.
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials.
Int J Radiat Oncol Biol Phys
; 116(3): 521-529, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36596347
7.
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials.
JAMA Netw Open
; 6(4): e238504, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37083668
8.
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601.
J Clin Oncol
; 40(27): 3172-3179, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35737923
9.
Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.
J Clin Oncol
; 37(3): 213-221, 2019 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30526194
10.
Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials.
Int J Radiat Oncol Biol Phys
; 104(5): 1057-1065, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30959123
11.
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.
Radiother Oncol
; 141: 137-143, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31540746
12.
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities.
Adv Radiat Oncol
; 3(3): 405-411, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30202809
13.
Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408.
Adv Radiat Oncol
; 2(4): 608-614, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29204528
14.
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.
Int J Radiat Oncol Biol Phys
; 98(2): 296-303, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28463149
15.
Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.
Eur Urol
; 69(2): 204-10, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26362090
16.
Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.
Int J Radiat Oncol Biol Phys
; 92(4): 863-73, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26104939
Resultados
1 -
16
de 16
1
Próxima >
>>